These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17389306)

  • 1. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke.
    Palumbo V; Boulanger JM; Hill MD; Inzitari D; Buchan AM;
    Neurology; 2007 Mar; 68(13):1020-4. PubMed ID: 17389306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukoaraiosis and lacunes are associated with poor clinical outcomes in ischemic stroke patients treated with intravenous thrombolysis.
    Arba F; Palumbo V; Boulanger JM; Pracucci G; Inzitari D; Buchan AM; Hill MD;
    Int J Stroke; 2016 Jan; 11(1):62-7. PubMed ID: 26763021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging.
    Singer OC; Humpich MC; Fiehler J; Albers GW; Lansberg MG; Kastrup A; Rovira A; Liebeskind DS; Gass A; Rosso C; Derex L; Kim JS; Neumann-Haefelin T;
    Ann Neurol; 2008 Jan; 63(1):52-60. PubMed ID: 17880020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1).
    Charidimou A; Pasi M; Fiorelli M; Shams S; von Kummer R; Pantoni L; Rost N
    Stroke; 2016 Sep; 47(9):2364-72. PubMed ID: 27491738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed Tomography--Verified Leukoaraiosis Is a Risk Factor for Post-thrombolytic Hemorrhage.
    Willer L; Havsteen I; Ovesen C; Christensen AF; Christensen H
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1126-30. PubMed ID: 25920756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of intracranial carotid artery calcification on the development of thrombolysis-induced intracerebral hemorrhage.
    Lin TC; Chao TH; Shieh Y; Lee TH; Chang YJ; Lee JD; Peng TI; Chang KC; Liou CW; Chang TY; Hung KL; Chang CH
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e455-62. PubMed ID: 23800497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolysis in acute stroke patients with cerebral small vessel disease.
    Pantoni L; Fierini F; Poggesi A
    Cerebrovasc Dis; 2014; 37(1):5-13. PubMed ID: 24355873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
    Saposnik G; Demchuk A; Tu JV; Johnston SC;
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
    Prabhakaran S; Rivolta J; Vieira JR; Rincon F; Stillman J; Marshall RS; Chong JY
    Arch Neurol; 2010 May; 67(5):559-63. PubMed ID: 20212195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study.
    Demchuk AM; Khan F; Hill MD; Barber PA; Silver B; Patel S; Levine SR;
    Cerebrovasc Dis; 2008; 26(2):120-5. PubMed ID: 18560214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. tPA treatment for acute ischaemic stroke in patients with leukoaraiosis.
    Ariës MJ; Uyttenboogaart M; Vroomen PC; De Keyser J; Luijckx GJ
    Eur J Neurol; 2010 Jun; 17(6):866-70. PubMed ID: 20236179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.
    Gouw AA; van der Flier WM; Fazekas F; van Straaten EC; Pantoni L; Poggesi A; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Scheltens P; Barkhof F;
    Stroke; 2008 May; 39(5):1414-20. PubMed ID: 18323505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume.
    Selim M; Fink JN; Kumar S; Caplan LR; Horkan C; Chen Y; Linfante I; Schlaug G
    Stroke; 2002 Aug; 33(8):2047-52. PubMed ID: 12154261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure management and evolution of thrombolysis-associated intracerebral hemorrhage in acute ischemic stroke.
    Mokin M; Kass-Hout T; Kass-Hout O; Zivadinov R; Mehta B
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):852-9. PubMed ID: 21703878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolysis in dementia patients with acute stroke: is it justified?
    Paciaroni M; Pantoni L
    Neurol Sci; 2017 Jan; 38(1):27-31. PubMed ID: 27699498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukoaraiosis, intracerebral hemorrhage, and functional outcome after acute stroke thrombolysis.
    Kongbunkiat K; Wilson D; Kasemsap N; Tiamkao S; Jichi F; Palumbo V; Hill MD; Buchan AM; Jung S; Mattle HP; Henninger N; Werring DJ
    Neurology; 2017 Feb; 88(7):638-645. PubMed ID: 28130468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of Recanalization, Intracerebral Hemorrhage, and Cerebral Edema After Intravenous Thrombolysis.
    Cheripelli BK; Huang X; MacIsaac R; Muir KW
    Stroke; 2016 Jul; 47(7):1761-7. PubMed ID: 27301943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis in experimental cerebral amyloid angiopathy and the risk of secondary intracerebral hemorrhage.
    Reuter B; Grudzenski S; Chatzikonstantinou E; Meairs S; Ebert A; Heiler P; Schad LR; Staufenbiel M; Hennerici MG; Fatar M
    Stroke; 2014 Aug; 45(8):2411-6. PubMed ID: 25005438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors.
    Lansberg MG; Albers GW; Wijman CA
    Cerebrovasc Dis; 2007; 24(1):1-10. PubMed ID: 17519538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.